Digital What is the future of technology in health data? From robot-assisted surgery to personalised disease treatment - technology can do some truly remarkable things.
Market Access Moderna’s missteps spotlight PMCPA’s role in upholding pharm... The pharmaceutical industry operates under a complex regulatory landscape, balancing government oversight with self-imposed standards.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
